These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22529240)

  • 1. Alternative estimates for the likelihood that a woman with screen-detected breast cancer has had her "life saved" by that screening.
    Heleno BM; Lindberg L; Brodersen J
    Arch Intern Med; 2012 Apr; 172(8):672. PubMed ID: 22529240
    [No Abstract]   [Full Text] [Related]  

  • 2. Likelihood that a woman with screen-detected breast cancer has had her "life saved" by that screening.
    Welch HG; Frankel BA
    Arch Intern Med; 2011 Dec; 171(22):2043-6. PubMed ID: 22025097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screen detection has both winners and losers.
    Keen JD; Keen J
    Arch Intern Med; 2012 Mar; 172(5):447. PubMed ID: 22412118
    [No Abstract]   [Full Text] [Related]  

  • 4. The debate over lifesaving benefit of screening mammography continues.
    Onitilo AA
    Arch Intern Med; 2012 Mar; 172(5):446-7. PubMed ID: 22412117
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening mammograms should not be underestimated.
    Costanza ME
    Arch Intern Med; 2012 Mar; 172(5):446. PubMed ID: 22412116
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening: simple messages ... sometimes.
    Wilt TJ; Partin MR
    Arch Intern Med; 2011 Dec; 171(22):2046-8. PubMed ID: 22025096
    [No Abstract]   [Full Text] [Related]  

  • 7. Realistic appraisal of the benefits of mammography.
    Lannin DR
    Arch Intern Med; 2012 Apr; 172(8):672-3. PubMed ID: 22529241
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of screening mammography on breast cancer mortality.
    Bleyer A; Baines C; Miller AB
    Int J Cancer; 2016 Apr; 138(8):2003-12. PubMed ID: 26562826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of model of care delivery on mammography use among elderly breast cancer survivors.
    Etim AE; Schellhase KG; Sparapani R; Nattinger AB
    Breast Cancer Res Treat; 2006 Apr; 96(3):293-9. PubMed ID: 16538537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Early Breast Cancer Screening on Mortality Among Young Survivors of Childhood Hodgkin's Lymphoma.
    Hodgson DC; Cotton C; Crystal P; Nathan PC
    J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26933010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old.
    Hendrick RE; Helvie MA; Hardesty LA
    AJR Am J Roentgenol; 2014 Dec; 203(6):1379-81. PubMed ID: 25415718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
    Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
    Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
    van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.
    Ng AK; Garber JE; Diller LR; Birdwell RL; Feng Y; Neuberg DS; Silver B; Fisher DC; Marcus KJ; Mauch PM
    J Clin Oncol; 2013 Jun; 31(18):2282-8. PubMed ID: 23610104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of modelling mammography screening strategies.
    Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
    Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-cancer screening.
    Fitzgerald SP
    N Engl J Med; 2012 Jan; 366(2):191; author reply 191-2. PubMed ID: 22236240
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast-cancer screening.
    Newman DH
    N Engl J Med; 2012 Jan; 366(2):191; author reply 191-2. PubMed ID: 22236239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.